ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1990

Effectiveness and Durability of a Brief Multidisciplinary Treatment Program for Patients with Fibromyalgia

Jessica Gehin1, Andy Abril2, Fernando Rivera3, Benjamin Wang4, Ronald Butendieck2, Florentina Berianu2, Kenneth Calamia2, Madeleine Allman1, Isabel Abril1 and Barbara Bruce1, 1Department of Psychiatry and Psychology, Mayo Clinic Florida, Jacksonville, FL, 2Division of Rheumatology, Mayo Clinic Florida, Jacksonville, FL, 3Division of Consultative and Diagnostic Medicine, Mayo Clinic Florida, Jacksonville, FL, 4Rheumatology, Mayo Clinic Florida, Jacksonville, FL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia, functional status, Intervention, self-management and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: ARHP Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FM) effects upwards of 60 million adults in the US alone. The disability and psychological distress often observed in these patients has been documented. Despite a recent update of diagnostic criteria for FM by the American College of Rheumatology (ACR) and the availability of demonstrated effective interventions for the treatment of FM, patients continue to be misunderstood, misdiagnosed and often left untreated. The purpose of this study is to examine the effectiveness and durability of a brief multidisciplinary intervention for patients with FM provided in a tertiary care setting in improving functioning and psychological distress.

Methods: Four hundred and twenty two (422) patients who participated in the Fibromyalgia Treatment Program between August 2015 and August 2016 were subjects in this study. The patients in the study were referred to a tertiary medical center for evaluation of fibromyalgia symptoms and were subsequently diagnosed with FM by meeting the 2010 ACR criteria. The patients were then enrolled in a 2-day multidisciplinary treatment program. Patients completed the Fibromyalgia Impact Questionnaire – Revised (FIQR), the Center for Epidemiological Studies of Depression Scale (CES-D), and the Pain Catastrophizing Scale (PCS) at the time of admission to the program and at 3-month and 6-month follow-up. The treatment program targeted Cognitive Behavioral Therapy (CBT) skills of evidence-based education regarding FM, chronic fatigue and central sensitization in addition to activity pacing, exercise, relaxation strategies, sleep hygiene, and moderation.

Results: The average age of patients was 48 years with a range of 19-79. The majority was female (90%). Duration of fibromyalgia symptoms on average was 10 years at the time of referral. At the time of admission to the program, patients were functionally impaired and psychologically distressed. The FIQR results on admission showed an average score of 60.0 which is in the severe level of impairment range. The average CES-D score on admission was 25.4 suggesting significant depression. The PCS scores on admission were on average 25 suggesting elevated levels of pain catastrophizing. At 3-month follow-up, the scores on all three measures were significantly decreased and the improvement observed across all scores were maintained or further improved at 6 month follow-up.

Conclusion: A brief multidisciplinary treatment program for patients with Fibromyalgia appears to be effective at decreasing functional impairment and psychological distress and the improvements are maintained or further improved at 3 and 6 month follow-up.


Disclosure: J. Gehin, None; A. Abril, None; F. Rivera, None; B. Wang, None; R. Butendieck, None; F. Berianu, None; K. Calamia, None; M. Allman, None; I. Abril, None; B. Bruce, None.

To cite this abstract in AMA style:

Gehin J, Abril A, Rivera F, Wang B, Butendieck R, Berianu F, Calamia K, Allman M, Abril I, Bruce B. Effectiveness and Durability of a Brief Multidisciplinary Treatment Program for Patients with Fibromyalgia [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/effectiveness-and-durability-of-a-brief-multidisciplinary-treatment-program-for-patients-with-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-and-durability-of-a-brief-multidisciplinary-treatment-program-for-patients-with-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology